Indaptus Therapeutics(INDP.US)

Last Updated 19:00:00 ET
longbridge loading

Indaptus Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
INDP
-7.52%
Earnings Watch·
US
INDP
-7.52%

Indaptus Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
INDP
-7.52%
Earnings Watch·
US
INDP
-7.52%

Earnings Scheduled For May 15, 2026

benzinga_article·
US
TRAW
+1.89%
US
INDP
-7.52%
US
MCB
+2.86%
benzinga_article·
US
TRAW
+1.89%
US
INDP
-7.52%
US
MCB
+2.86%

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | INDP Stock News

StockTitan·
US
INDP
-7.52%
US
BIB
+4.98%
US
SBIO
+3.75%
StockTitan·
US
INDP
-7.52%
US
BIB
+4.98%
US
SBIO
+3.75%

12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga_article·
US
ESPR
0.00%
US
CUE
+0.64%
US
PBE
+1.60%
benzinga_article·
US
ESPR
0.00%
US
CUE
+0.64%
US
PBE
+1.60%

Indaptus Therapeutics names Tim Ruan and Yi Zhang as independent directors; Matthew McMurdo resigns

TradingView·
US
INDP
-7.52%
US
LABU
+11.76%
US
ARKG
+5.05%
TradingView·
US
INDP
-7.52%
US
LABU
+11.76%
US
ARKG
+5.05%
© 2026 Longbridge｜Disclaimer